
Growth in U.S. clinical pipelines 2015-2019, by disease area
In 2019, the number of clinical pipelines related to metabolic diseases increased by around 66 percent over the given years in the United States. Clinical pipelines in the respiratory area grew by around 19 percent in the same time period.